________
Source: Jerusalem Post
Has Israel become the over-inoculation nation on COVID-19? - analysis
The policy presents particular difficulties for those who were not vaccinated with Pfizer and for whom a booster might not be advisable or available.
By MAAYAN JAFFE-HOFFMAN | OCTOBER 14, 2021
Jerusalem resident Phillip Brieff is seen getting the third COVID-19 booster shot at a Meuhedet clinic, on August 1, 2021. (photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)
Should people be forced to get a COVID-19 booster just for the privilege of entering Israel?
The Health Ministry is requiring a third shot for everyone entering the country through Ben-Gurion Airport more than six months after they were vaccinated, regardless of with which vaccine they were inoculated, or they are forced to be isolated a minimum of seven days.
The policy presents particular difficulties for those who were not vaccinated with Pfizer and for whom a booster might not be advisable or available.
People who received two shots of Moderna, for example, are being unofficially told to get a Pfizer vaccine booster, which in the US is only approved for people 65 years and older, or who are at high risk of getting coronavirus or developing severe disease.
Moreover, on Tuesday at the Jerusalem Post Annual Conference, Dr. Sharon Alroy-Preis, head of Public Health in the Health Ministry, said that Palestinians who were vaccinated with two shots of Moderna six months ago had lost their Green Passes. They can still enter Israel to go to work, but they cannot visit any establishments that require a Green Pass unless they take an antigen test.
The situation raises medical and ethical questions, since it is still unclear if, or certainly when, a booster shot should be required for people who received Moderna.
A key US Food and Drug Administration panel was set to hold a meeting late Thursday to discuss and vote on the use of Moderna's COVID-19 booster shots. Depending on the results of that meeting, the FDA could make a final decision within days as to whether the booster should be used. Then, the Centers for Disease Control and Prevention (CDC) would make specific recommendations on who should get the shots.
While at press time, a recommendation had still not been reached, it is unlikely the FDA will vote in favor of a mass Moderna booster campaign.
In Israel, the country has seen what Alroy-Preis described in other interviews as a "break in the epidemic curve" thanks to its booster shot campaign, which now includes around 50% of the eligible population. However, Israelis have almost exclusively taken the Pfizer vaccine.
Moderna, like Pfizer, is a novel mRNA vaccine. Their basic technology is the same. Therefore, it can be assumed that the Moderna vaccine's effectiveness will also wane.
However, the vaccines are not identical.
Moderna is two shots of 100 micrograms while Pfizer is only 30. In addition, the two Pfizer doses are administered three weeks apart compared to Moderna's four.
Some studies also show that longer gaps between administering these vaccines make them last longer and that more neutralizing antibodies are developed. Nearly all research has shown that Moderna's effectiveness wanes slower than Pfizer's.
Please go to Jerusalem Post to read more.
The policy presents particular difficulties for those who were not vaccinated with Pfizer and for whom a booster might not be advisable or available.
People who received two shots of Moderna, for example, are being unofficially told to get a Pfizer vaccine booster, which in the US is only approved for people 65 years and older, or who are at high risk of getting coronavirus or developing severe disease.
Moreover, on Tuesday at the Jerusalem Post Annual Conference, Dr. Sharon Alroy-Preis, head of Public Health in the Health Ministry, said that Palestinians who were vaccinated with two shots of Moderna six months ago had lost their Green Passes. They can still enter Israel to go to work, but they cannot visit any establishments that require a Green Pass unless they take an antigen test.
Israel's head of public health Dr. Sharon Alroy-Preis is seen speaking at the Jerusalem Post annual conference at the Museum of Tolerance in Jerusalem, on October 12, 2021. (credit: AVSHALOM SASSONI/MAARIV)
The situation raises medical and ethical questions, since it is still unclear if, or certainly when, a booster shot should be required for people who received Moderna.
A key US Food and Drug Administration panel was set to hold a meeting late Thursday to discuss and vote on the use of Moderna's COVID-19 booster shots. Depending on the results of that meeting, the FDA could make a final decision within days as to whether the booster should be used. Then, the Centers for Disease Control and Prevention (CDC) would make specific recommendations on who should get the shots.
While at press time, a recommendation had still not been reached, it is unlikely the FDA will vote in favor of a mass Moderna booster campaign.
In Israel, the country has seen what Alroy-Preis described in other interviews as a "break in the epidemic curve" thanks to its booster shot campaign, which now includes around 50% of the eligible population. However, Israelis have almost exclusively taken the Pfizer vaccine.
Moderna, like Pfizer, is a novel mRNA vaccine. Their basic technology is the same. Therefore, it can be assumed that the Moderna vaccine's effectiveness will also wane.
However, the vaccines are not identical.
Moderna is two shots of 100 micrograms while Pfizer is only 30. In addition, the two Pfizer doses are administered three weeks apart compared to Moderna's four.
Some studies also show that longer gaps between administering these vaccines make them last longer and that more neutralizing antibodies are developed. Nearly all research has shown that Moderna's effectiveness wanes slower than Pfizer's.
Please go to Jerusalem Post to read more.
________
What financial firm is making all this possible? BlackRock...
Part of the digital domain is to destroy the genders:
Only Fink ("king of Wall Street") knows...
Readers can be absolutely certain Israel will dominate those climate tech firms BlackRock's Fink refers to as "unicorn firms":
If you don't think China's love affair with Jews (Israel) is significant and these social credit digital surveillance systems being built in China likely invested in by BlackRock aren't coming to America, you should probably reconsider your love affair with your smart phone.
China's Belt & Road Initiative is good for Israel. Most analysts leave this out of their reporting. It is in BlackRock's best interests to be favorable towards China's infrastructure construction in Eurasia.
Coronavirus is the cover story. Chinese children will be brought into these digital data extraction and surveillance systems with the injections used as the platform to get this accomplished.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.